17-43094640-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 12P and 8B. PVS1PS1_ModeratePM2BP6_Very_Strong

The NM_001407966.1(BRCA1):​c.3G>A​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,168 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)

Consequence

BRCA1
NM_001407966.1 start_lost

Scores

14
4

Clinical Significance

Benign reviewed by expert panel U:1B:7

Conservation

PhyloP100: 1.53

Publications

15 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 461 pathogenic variants. Next in-frame start position is after 235 codons. Genomic position: 43093940. Lost 0.149 part of the original CDS.
PS1
Another start lost variant in NM_001407966.1 (BRCA1) was described as [Pathogenic] in ClinVar
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 17-43094640-C-T is Benign according to our data. Variant chr17-43094640-C-T is described in ClinVar as Benign. ClinVar VariationId is 55743.Status of the report is reviewed_by_expert_panel, 3 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001407966.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_007294.4
MANE Select
c.891G>Ap.Met297Ile
missense
Exon 10 of 23NP_009225.1P38398-1
BRCA1
NM_001407966.1
c.3G>Ap.Met1?
start_lost
Exon 2 of 15NP_001394895.1C9IZW4
BRCA1
NM_001407967.1
c.3G>Ap.Met1?
start_lost
Exon 2 of 15NP_001394896.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000497488.2
TSL:1
c.3G>Ap.Met1?
start_lost
Exon 2 of 15ENSP00000418986.2C9IZW4
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.891G>Ap.Met297Ile
missense
Exon 10 of 23ENSP00000350283.3P38398-1
BRCA1
ENST00000471181.7
TSL:1
c.891G>Ap.Met297Ile
missense
Exon 10 of 24ENSP00000418960.2P38398-7

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152168
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251232
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
34
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152168
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41432
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000557
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.00000824
AC:
1

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Breast-ovarian cancer, familial, susceptibility to, 1 (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Uncertain
0.087
D
BayesDel_noAF
Uncertain
0.070
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.53
D
Eigen
Benign
-0.042
Eigen_PC
Benign
0.064
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.88
D
M_CAP
Uncertain
0.10
D
MetaRNN
Uncertain
0.49
T
MetaSVM
Uncertain
0.12
D
MutationAssessor
Uncertain
2.4
M
PhyloP100
1.5
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.2
D
REVEL
Uncertain
0.59
Sift
Uncertain
0.023
D
Sift4G
Benign
0.061
T
Polyphen
0.074
B
Vest4
0.38
MutPred
0.42
Gain of helix (P = 0.0325)
MVP
0.86
MPC
0.098
ClinPred
0.59
D
GERP RS
4.0
Varity_R
0.27
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80357103; hg19: chr17-41246657; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.